Yttrium Y-90 ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Yttrium Y-90 ibritumomab tiuxetan, covering 2018-05-14 to 2018-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma [Phase 1]